Reproductive carrier screening, explained.
Reproductive carrier screening is a blood test that shows whether you carry a gene change linked to a serious inherited condition. Carriers are healthy, so most have no idea. The standard Australian screen covers cystic fibrosis, spinal muscular atrophy and fragile X syndrome.
The point of doing it is timing. Screening before a pregnancy is when the widest range of options is open and nothing has to be decided in a hurry. RANZCOG guidelines now recommend it is offered to every couple planning a pregnancy, not only to those with a family history.
What it screens for
The standard three-gene screen looks for gene changes linked to cystic fibrosis, spinal muscular atrophy and fragile X syndrome. Together these are among the most common serious inherited conditions in Australia. Expanded panels screen hundreds of genes; they find more, but they also return more uncertain results, so they suit some couples better than others.
Two of the three work the same way. Cystic fibrosis and spinal muscular atrophy are recessive: a child is affected only if they inherit a gene change from both parents. Fragile X is different, because it sits on the X chromosome and the mother's result alone determines the chance, which is why a female carrier's partner does not need testing for it.
How likely is it that I am a carrier?
Who should consider it, and when
- Anyone planning a pregnancy. This is the recommendation, regardless of family history, because most carriers have no family history at all.
- Couples already pregnant. Still useful, and worth doing early, because results take two to three weeks and options narrow as the pregnancy progresses.
- Anyone with a relevant family history. Here a genetics service, rather than a standard screen, is often the right first stop.
- Couples considering IVF. Screening results can inform decisions before treatment starts rather than during it.
Ideally, do it before you start trying. That is when a result changes what is possible rather than only what is known.
What happens if I am a carrier
- Your reproductive partner is tested for the same gene. For fragile X, the mother's result alone determines the chance, so partner testing is not required.
- If both of you carry a change in the same recessive gene, each pregnancy has a one in four chance of an affected child. A genetic counsellor talks you through the options, which include testing during pregnancy and, for some couples, IVF with embryo testing.
- If only one of you is a carrier, the chance of an affected child is very low and no further action is usually needed.
- Genetic counselling is available to anyone with a carrier result, and it is the part of the process that matters most. A number without a conversation is not much use.
The Medicare rebate
Since 1 November 2023, the three-gene carrier screen has attracted a Medicare rebate (item 73451), once per lifetime, when your own GP or specialist requests it for reproductive planning. There is no age limit and no family-history requirement, and if you are found to carry cystic fibrosis or spinal muscular atrophy, testing your reproductive partner for the same gene is rebated too (item 73452).
That is worth knowing before you pay for anything. Expanded panels are not covered in any setting. KnowLuna's three-gene screen is billed privately as a self-pay test, so no Medicare benefit is claimed for it, and your once-per-lifetime rebate stays available through your GP. If cost is the deciding factor, ask your GP first. Our carrier screening cost article sets out the routes side by side.
KnowLuna's version exists for people who want it done quickly, explained plainly, or bundled with a preconception check. It is not the cheapest route and we would rather say so.
How it differs from NIPT
They are easy to confuse and they answer different questions. Carrier screening tests you, before or during pregnancy, and asks what you might pass on. NIPT tests a current pregnancy and estimates the chance of a chromosome condition in that pregnancy. Carrier screening is done once in a lifetime; NIPT is done in each pregnancy. Neither is a diagnostic test, and a carrier result says nothing about whether a current pregnancy is affected.
What the test involves
One sample. The default is a home swab or saliva kit posted to you with a prepaid return satchel, and you can collect at an accredited (NATA/RCPA) centre or with a nurse home visit instead. No fasting, no timing rules, no preparation. Results take about two to three weeks because the laboratory work is genetic rather than biochemical. Your report explains what was screened and what was found, and any carrier result is followed up by a doctor and by genetic counselling.
Common questions
Is carrier screening covered by Medicare?
The three-gene screen for cystic fibrosis, spinal muscular atrophy and fragile X has been rebated since November 2023, once per lifetime, when your own GP or specialist requests it for reproductive planning. Partner testing is rebated if you are found to carry cystic fibrosis or spinal muscular atrophy. Expanded panels are not covered, and a self-pay test like ours is billed privately, so your once-per-lifetime rebate stays available through your GP.
What if both partners are carriers?
If you both carry a change in the same recessive gene, each pregnancy has a one in four chance of an affected child, a one in two chance of a healthy carrier, and a one in four chance of neither. A genetic counsellor explains the options, which include testing during pregnancy and, for some couples, IVF with embryo testing.
When should carrier screening be done?
Ideally before you start trying, because results take two to three weeks and a positive result may lead to partner testing, which takes longer again. It is still worth doing in early pregnancy. Doing it once covers you for future pregnancies with the same partner, since your own genes do not change.
Is carrier screening the same as NIPT?
No. Carrier screening tests you, looking at what you could pass on, and is done once in a lifetime. NIPT tests a current pregnancy for the chance of a chromosome condition, and is done each time. Some couples have both, at different points, and they answer entirely different questions.
Is fragile X inherited from the mother or the father?
The fragile X gene change sits on the X chromosome, and the expansion that causes the condition passes through the mother's line. That is why a woman's result determines the chance for a pregnancy and her partner is not tested for it. A premutation can also affect the carrier's own health, so a female carrier result is followed up with genetic counselling.
Sources and further reading
- Pathology Tests Explained (RCPA): reproductive carrier screening
- RANZCOG: Genetic carrier screening (statement C-Obs 63)
- Medicare Benefits Schedule: item 73451, reproductive carrier screening (CF, SMA, fragile X)
- Pregnancy, Birth and Baby: genetic carrier screening
- Pregnancy, Birth and Baby: genetic counselling
- Healthdirect: genetic disorders
General information only, not medical advice. If your symptoms are severe or sudden, see a doctor promptly. This page does not replace a consultation with a doctor who knows your history; read our medical disclaimer.